Biography

My clinical and research focus for the past 20 years has been to improve the efficacy of hematopoietic stem cell transplantation. I was recruited to Emory University in 1994 and have been the Director of the Bone Marrow and Stem Cell Transplant Program since 1998. I have built a NIH-funded translational research program at Emory focused on developing novel technologies to improve transplant outcomes. Our laboratory is focused on studying the role of specific donor dendritic cell subsets in mouse BMT model systems. I served as a member of the protocol team that designed the BMT CTN 0201 study, the randomized clinical trial of bone marrow versus G-CSF mobilized blood stem cell grafts collected from volunteer unrelated donors. In addition to managing a laboratory research program, I am active in clinical care. Last year our adult transplant program performed over 450 transplants. I previously served as Associate Director for Clinical Research at the Winship Cancer Institute. I am gratified by my on-going collaboration with Dan Kalman, and excited that an oral leukemia drug might be repurposed to treat patients with multi-drug resistant TB. I am highly motivated and have the necessary clinical resources and leadership experience to continue and expand my collaboration with Dr. Kalman in the development of Gleevec for TB and TB/HIV and lead the Phase 1 safety studies in human patients.

View Emory School of Medicine faculty profile

View Winship Cancer Institute of Emory University clinician profile